It works by stimulating insulin production and reducing the release of glucagon, which keeps blood sugar levels in check
Over 17,600 participants received either Wegovy or placebo
Our global teams are excited to provide true integration of our expertise across the pharma supply chain to meet the increasing demand for GLP-1 peptide therapeutics and ultimately, improve patient outcomes. [Photo by CordenPharma] CordenPharmas Integrated Supply from peptide drug substance to injectable and oral solid dosage manufacturing
The condition can cause severe and deadly complications, including: Breathing problems Infection Kidney failure Malnutrition Pancreatic cancer Pseudocyst (fluid and debris build-up in a pocket of the pancreas that can rupture, causing internal bleeding and infection) Lawsuits allege that people taking GLP-1 RAs like tirzepatide may be at risk of developing necrotizing pancreatitis
Rozman, K., Gorski, J., Rozman, P